Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 3 April 1981:
Vol. 212. no. 4490, pp. 49 - 51
DOI: 10.1126/science.7209515

Articles

Science, Vol 212, Issue 4490, 49-51
Copyright © 1981 by American Association for the Advancement of Science


articles

Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone

WH Sawyer, PK Pang, J Seto, M McEnroe, B Lammek, and M Manning

Four new synthetic analogs of vasopressin (antidiuretic hormone) can antagonize the antidiuretic response to intravenous vasopressin in anesthetized, water-loaded rats. They also cause a diuresis resembling that of diabetes insipidus when given intraperitoneally to conscious rats. Such antagonists may prove to be useful both pharmacologically and therapeutically.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The role of V2 vasopressin antagonists in hyponatremia.
C. Palm, D. Reimann, and P. Gross (2001)
Cardiovasc Res 51, 403-408
   Abstract »    Full Text »    PDF »
Long-Term Aquaretic Efficacy of a Selective Nonpeptide V2-Vasopressin Receptor Antagonist, SR121463, in Cirrhotic Rats.
W. Jiménez, C. S.-L. Gal, J. Ros, C. Cano, P. Cejudo, M. Morales-Ruiz, V. Arroyo, M. Pascal, F. Rivera, J.-P. Maffrand, et al. (2000)
J. Pharmacol. Exp. Ther. 295, 83-90
   Abstract »    Full Text »
Comparison of Two Aquaretic Drugs (Niravoline and OPC-31260) in Cirrhotic Rats with Ascites and Water Retention.
M. Bosch-Marcé, J.-L. Poo, W. Jiménez, N. Bordas, A. Leivas, M. Morales-Ruiz, R. M. Muñoz, M. Pérez, V. Arroyo, F. Rivera, et al. (1999)
J. Pharmacol. Exp. Ther. 289, 194-201
   Abstract »    Full Text »
Endogenous vasopressin does not mediate hypoxia-induced anapyrexia in rats.
A. A. Steiner, E. C. Carnio, J. Antunes-Rodrigues, and L. G. S. Branco (1999)
J Appl Physiol 86, 469-473
   Abstract »    Full Text »    PDF »
Role of nitric oxide in systemic vasopressin-induced hypothermia.
A. A. Steiner, E. C. Carnio, J. Antunes-Rodrigues, and L. G. S. Branco (1998)
Am J Physiol Regulatory Integrative Comp Physiol 275, R937-R941
   Abstract »    Full Text »    PDF »
Comparison of the Water Diuretic Activity of Kappa Receptor Agonists and a Vasopressin Receptor Antagonist in Dogs.
D. P. Brooks, M. Valente, G. Petrone, P. D. Depalma, M. Sbacchi, and G. D. Clarke (1997)
J. Pharmacol. Exp. Ther. 280, 1176-1183
   Abstract »    Full Text »
Effect of Renal Perfusion Pressure on Renal Interstitial Hydrostatic Pressure and Sodium Excretion : Role of Vasopressin V1 and V2 Receptors.
T. Nakamura, T. Sakamaki, T. Kurashina, K. Sato, Z. Ono, and K. Murata (1995)
Hypertension 25, 866-871
   Abstract »    Full Text »
OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist.
Y Yamamura, H Ogawa, T Chihara, K Kondo, T Onogawa, S Nakamura, T Mori, M Tominaga, and Y Yabuuchi (1991)
Science 252, 572-574
   Abstract »    PDF »
A conformationally constrained vasopressin analog with antidiuretic antagonistic activity.
G Skala, C. Smith, C. Taylor, and J. Ludens (1984)
Science 226, 443-445
   Abstract »    PDF »
A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog.
N Horiuchi, M. Holick, J. Potts Jr, and M Rosenblatt (1983)
Science 220, 1053-1055
   Abstract »    PDF »
Role of Vasopressin in Abnormal Water Excretion in Cirrhotic Patients.
D. BICHET, V. SZATALOWICZ, C. CHAIMOVITZ, and R. W. SCHRIER (1982)
Ann Intern Med 96, 413-417
   Abstract »    PDF »
Antagonists of Vasopressor and Antidiuretic Responses to Arginine Vasopressin.
M. MANNING and W. H. SAWYER (1982)
Ann Intern Med 96, 520-522
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)